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Abstract : In order to analyze the role of a new structured fibrous dressing in the proliferative stage of chronic 
wound healing in hard to heal wounds, a case study was performed on a stagnant venous ulcer, which remained 
non-healed in the past 7 months. All chronicity factors that could affect wound healing were excluded, including 
biofilm (with the use of polihexanide+betaine, Prontosan range), and compression therapy was provided. The 
results were very interesting with healing achieved in 7 weeks of treatment. Most of times it is not easy to find/select 
a dressing to promote granulation and epithelisation, once ideal cleaning/debridement and bioburden control are 
achieved. Some dressings do not provide a good healing rate, lead to bioburden elevation during time and 
recurrence in the use of antimicrobials. Other options to promote proliferation are very expensive and need a 
secondary dressing. Treatment with kerrafibre showned to be very cost effective. Its is also implicit the important 
role of advanced wound care centers versus conventional care. 
This case study was originally presented as a poster at Wounds UK 2014 Conference, at Harrogate, England, 
United Kingdom. 
Keywords: Fibrous Dressings; Proliferative Stage, Hard to Heal Wounds. 
Resumo: A fim de analisar o papel de um novo penso fibroso na fase proliferativa da cicatrização da ferida crônica 
de difícil cicatrização, um estudo de caso foi realizado numa úlcera venosa estagnada, que permaneceu por 
cicatrizar nos últimos 7 meses. Todos os factores de cronicidade que pudessem afectar a cicatrização foram 
excluídas, incluindo o biofilme (com o uso de polihexanida + betaína, da gama Prontosan) sendo também utilizada 
terapia compressiva. Os resultados foram muito interessantes com a obtenção da cicatrizarão ao fim de 7 semanas 
de tratamento. Na maioria das vezes, não é fácil de encontrar / selecionar um curativo para promover a granulação 
e epitelização, uma vez alcançada a limpeza ideal / desbridamento e controle de carga biológica. Alguns pensos 
não fornecem uma boa taxa de cicatrização, e podem ocasionar elevação carga microbiana ao longo do tempo e a 
reincidência no uso de antimicrobianos. Outras opções para promover a proliferação são muito dispendiosas e 
precisam de um penso secundário. O tratamento com kerrafibre revelou ser muito rentável. Fica também implícita a 
importância do papel dos centros avançados de tratamento de feridas versus o tratamento convencional. Este 
estudo de caso foi originalmente apresentado como um Poster no Congresso Wounds UK 2014, em Harrogate, 
Inglaterra, Reino Unido. 
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Introduction 
Approximately 1 to 2% of the population will 
suffer from leg ulceration, with lower limb chronic 
venous insufficiency affecting up to 50% of the 
adult population.1 There are many direct risk 
factors for venous ulceration including: varicose 
veins, deep vein thrombosis, chronic venous 
insufficiency, poor calf muscle function, arterio-
venous fistulae, obesity, and history of leg 
fracture. Recurrent venous ulceration occurs in 
up to 70% of those at risk. Many venous ulcers 
are painful, so appropriate pain relief and advice 
should be given.2 It is recognised that about 
70% of ulcers are venous in origin, 10–15% are 
arterial, with about 15% of leg ulcer patients  
having mixed aetiology of both venous and 
arterial disease.3  
This case study describes the management of 
an 86-year-old female who lived independently 
and was socially active in her community. She 
had hypertension, venous insufficiency, and had 
suffered 2 episodes of venous ulcers in the 
same location. She had an active venous leg 
ulcer, which had been present for 7 months 
(Figure 1). It was evaluated in line with clinical 
guidelines, which suggest that all patients with 
chronic venous leg ulcers should have an ankle 
brachial pressure index (ABPI) performed prior 
to treatment and the ulcer edge should be 
measured as it often gives a good indication of 
progress of wound healing.4 
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Method  
The patient’s leg ulcer was located mainly in the 
retromalleolar region, on the distal third of the 
medial aspect of the left leg. The leg had been 
eczematous, and became itchy and blistered 
before ulcerating. The ulcer measured 3.7cm2 
and the ABPI measurement was 0.91, 
suggesting only mild arterial disease.2 There 
was some slough present, with signs of infection 
and critical colonisation. The wound was 
malodorous, with moderate fibrinous exudate. 
 The patient wore compression stockings and 
had previously been treated with a sodium 
carboxymethylcellulose dressing, both with and 
without silver.  
The treatment plan was to clean the wound and 
so exclude biofilm, remove debris and slough. 
Prontosan Solution (B. Braun) was used to clean 
the wound during the first 3 weeks. Prontosan 
Gel (B. Braun) was then used in conjunction with 
a silver alginate foam dressing, twice weekly for 
2 weeks, to prevent biofilm re-organisation, 
reduce signs of infection, and manage exudate. 
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Subsequently, KerraFibre (Crawford Healthcare) 
was used twice a week for 2 weeks and weekly 
for 3 weeks. KerraFibre was chosen due to the 
ability of its alginate fibres to help absorb and 
wick away debris from the wound surface, 
helping to keep the wound clean and so 
reducing bioburden. It was also chosen due to 
its ability to absorb and retain moderate to large 
amounts of fibrinous exudate, and so maintain 
the ideal moist wound healing environment to 
allow granulation and epithelialisation. During 
treatment the patient also wore 2-layer 
compression bandages (Urgo K2). Compression 
therapy may be safely used in leg ulcer patients 
with ABPI≥0.8.4  
Results  
Granulation and epithelialisation were achieved 
after 7 weeks of treatment (Figure 6). By limiting 
wound secretions and minimising bacterial 
contamination KerraFibre helped to create the 
ideal healing environment for the wound bed and 
the wound healed before 2 months of treatment. 
The dressing was accepted well by the patient, 
who described it as comfortable.  
Discussion  
Venous leg ulcers often become infected2 so it is 
important to control the bioburden and manage 
the wound exudate. KerraFibre combines a high-
calcium alginate fibre with a high-sodium 
superabsorbent sulphonated co-polymer gel. 
The combination of the alginate wicking layer 
that forms a gel on contact with wound exudate, 
and the superabsorbent co-polymer gel, 
maintains the moist wound environment whilst 
enhancing fluid management.  
KerraFibre is suitable for moderate to highly 
exuding wounds with no need for a secondary 
dressing. Integrated into 1 structure, each of its 
3 layers performs a different role – but when 
combined with the innovative hexagonal 
structure, the result is a dressing that absorbs 
exudate and locks it away. 
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Conclusion  
Granulation and epithelialisation were assisted 
by KerraFibre in the management of this 
recurrent venous ulcer. After debridement, 
cleaning of the wound and bioburden control are 
achieved, dressings such as KerraFibre, which 
reduce slough and exudate in a wound, help to 
minimise bacterial contamination, promote 
granulation and epithelisation. Their effective 
wound healing is also very cost-effective in 
managing chronic venous leg ulcers.  
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